Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by herbaciouson Mar 24, 2011 5:08pm
214 Views
Post# 18336955

WHY NOW BEFORE THE CORE

WHY NOW BEFORE THE COREARA will rocket the share price when its launched!

CORE WILL SEND THE SHARE PRICE TO THE MOON!

whats CORE

fOLLOWING THE EXPECTED LAUNCH OF AURA  VERISANTE  EXPECTS TO INTRODUCE CORE.

                                                         FOR THE DETECTION OF LUNG CANCER


Initial focus will be on lung cancer, CORE was also developed by THE BC CANCER AGENCY and is built on the AURA platform.

VERISANTE  will work with theVancouver General Hospital's(VGH) LUNG CANCER CENTRE on development of a commercial CORE PROTOTYPE.

VGA'S Dr. Stephen Lam will be directly involved in the project.

Dr.lam credentials include professor of medicine at the University of BC, chair of the lung Tumour group and leader of the lung Cancer Prevention Program at the BC Cancer Aagency.

He is also co-inventor of LIFE-LUNG , a device used to detect pre-invasive lung cancers which is being used in more than 150 major hospitals worldwide.

Removal of a suspected cancerous lesion in the lung is highly invasive! Accurate diagnosis prior to the biopsy is therefore important in order to optimize patient care .
Better diagnosis also maximizes health care resources and reduces overall costs.

The web site sais that "the Verisante CORE device determines with exceptual accuracy if a lesion is malignat or benign.

Through this quick and non-evasive verification process , the Verisante Core  device prevents unnecessary biopsies
and the resulting stress and health-care risks and costs that occompany the biopsy procedure.



do your own due diligence

herb




Bullboard Posts